Dr. Professor Zhang Yonghong

• Professor Zhang Yonghong is a highly respected pediatric haematologist and oncologist, and currently serves as Director of the Pediatric Haematology/Oncology Departments.
• She has dedicated over 40 years to clinical practice in pediatric haematology and oncology since joining the Haematology Department of Beijing Children’s Hospital in 1983.
• Her clinical expertise spans the diagnosis and treatment of a broad spectrum of pediatric blood disorders and childhood cancers.
• In 2003, Professor Zhang helped establish the pediatric lymphoma speciality at Beijing Children’s Hospital and became its head.
• She later spearheaded the formation of the China-Net Childhood Lymphoma (CNCL) in 2017, serving as its leader.
• She was the first in China to implement refined, internationally aligned stratified chemotherapy protocols for pediatric lymphoma, a milestone that significantly improved treatment outcomes and raised nationwide cure rates to 80%-90%.
• Professor Zhang has led multiple provincial- and municipal-level research projects and remains deeply engaged in clinical research, academic publishing, and international collaboration.
• She has also served as a Visiting Scholar at world-renowned institutions, including St. Jude Children’s Research Hospital (USA), the Prince of Wales Hospital Children’s Oncology Centre at the Chinese University of Hong Kong, and MD Anderson Cancer Centre (USA), further reinforcing her global influence in pediatric oncology.

Conditions treated byProfessor Zhang Yonghong

• Pediatric lymphoma
• Pediatric blood diseases
• Pediatric solid tumors
• Childhood hematologic and oncologic disorders

Area of Interest

• Pediatric hematology
• Pediatric oncology
• Pediatric lymphoma
• Stratified chemotherapy protocols
• Precision treatment of childhood cancers

Work Experiences

• She serves as Director of the Pediatric Haematology/Oncology Departments and has been engaged in clinical practice in pediatric haematology and oncology since 1983.
• In 2003, she founded and became the Head of the Pediatric Lymphoma Speciality at Beijing Children’s Hospital, and in 2017, she led the establishment of the China-Net Childhood Lymphoma (CNCL), serving as its leader.